表紙
市場調查報告書

基因編輯的全球市場:技術

Genome Editing: Technologies and Global Markets

出版商 BCC Research 商品編碼 355580
出版日期 內容資訊 英文 148 Pages
訂單完成後即時交付
價格
基因編輯的全球市場:技術 Genome Editing: Technologies and Global Markets
出版日期: 2019年02月18日內容資訊: 英文 148 Pages
簡介

全球基因編輯市場,預計從2018年的14億美元,到2022年擴大到44億美元。預計市場2018年∼2023年以25.7%的年複合成長率成長。

本報告提供全球基因編輯市場相關調查分析,市場概要,市場區隔與預測,各市場區隔的市場預測,競爭情形,主要企業等相關的系統性資訊。

第1章 簡介

第2章 摘要和亮點

第3章 目前基因編輯技術

  • 概要
  • 基因編輯的歷史
  • 基因編輯比較
  • CRISPR-Cas9發現
  • CRISPR-Cas9系統的結構要素
  • CRISPR-Cas的結構
  • CRISPR-Cas9系統的優點等

第4章 基因編輯的用途

  • 簡介
  • 學術研究
  • 藥物研發、開發
  • 臨床治療
  • 非基因改造育種
  • 診斷
  • 其他

第5章 市場區隔與預測

  • 市場概要
  • 市場企業
  • 市場區隔:各地區
  • 市場區隔:各用途
  • 市場區隔:各技術
  • 市場區隔:各產品類型

第6章 受託服務市場分析

  • 市場概要
  • 市場企業
  • 市場佔有率與預測
  • 產品市場區隔的比較

第7章 研究市場分析

  • 市場概要
  • 市場佔有率與預測
  • 專利分析
  • 出版分析
  • 研究結果分析

第8章 藥物開發市場分析

  • 市場概要
  • 市場佔有率與預測

第9章 農業生物科技市場分析

  • 市場概要
  • 市場佔有率與預測

第10章 臨床市場分析

  • 市場概要
  • 市場佔有率與預測
  • 非臨床市場與比較

第11章 競爭情形和機會

  • 概要
  • 成長策略
  • 機會

第12章 基因編輯影響市場的要素

  • 簡介
  • 促進因素
  • 限制市場成長的要素

第13章 企業簡介

關於BCC Research

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: BIO146B

Report Highlights:

The global market for genome editing should grow from $1.4 billion in 2018 to $4.4 billion by 2023, with a compound annual growth rate (CAGR) of 25.7% for the period of 2018-2023.

U.S. market for genome editing should grow from $535 million in 2018 to $1.7 billion by 2023, with a CAGR of 26.6% for the period of 2018-2023.

Asia-Pacific market for genome editing should grow from $398 million in 2018 to 1.2 billion by 2023, with a CAGR of 25.2% for the period of 2018-2023.

Report Scope:

This study is focused on the market side of genome editing and provides a comprehensive review of genome editing technologies, along with updates on the latest related progress in the field. Different market segments for this specific market are covered. For example, application-based market segments include academic research, drug development, clinical therapy, non-transgenic breeding and other applications; and regional market segments include the U.S., Europe, Asia-Pacific and the Rest of World.

Specifically centered on the market itself and its environment, this report covers almost all aspects of the global genome editing industry, including its technologies, applications and markets, which are further segmented and analyzed by region, product type, application and technology. The report forecasts the sizes and trends of the global market as well as each of its segments. It details recent technical breakthroughs as well as major technical issues to overcome before genome editing is applied to clinical applications. The growth driving factors and the factors that may limit the market's growth are identified. The ethical issues, regulatory issues and intellectual property rights issues are discussed. The trends of patent publications, research publications and research funding in the genome editing area are analyzed. A competitive landscape, including various growth strategies and opportunities, are discussed. Comprehensive company profiles of the major players in the current genome editing field are also included in this report. In addition, the contract services market and clinical applications market are also discussed.

Report Includes:

  • 44 tables
  • A comprehensive overview of the global markets and technologies for genome editing within the industry
  • Analyses of global market trends, with data from 2017, 2018, and projections compound annual growth rates (CAGRs) through 2023
  • Segmentation of the global market by geographical regions, product types, technology types and end-user application areas
  • Emphasis on the market size and segmentation of gene editing products, including gene editing tools, cell lines, animal models and potential clinical products
  • Current status on the intellectual property right of the CRISPR-Cas9 genome editing technology
  • Discussion of the ethical and regulatory issues, as well as patent analysis, publication analysis and research funding in this area
  • Profiles of key players in the industry, including Horizon Discovery, Thermo Fisher Scientific, CRISPR Therapeutics, Caribou Biosciences Inc., Editas Medicine and Vertex

Table of Contents

Chapter 1: Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Intended Audience
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2: Summary and Highlights

  • Key Drivers of Market Growth

Chapter 3: Current Genome Editing Technologies

  • Overview
  • History of Genome Editing
  • Comparison of Genome Editing
  • Discovery of CRISPR-Cas9
  • Components of CRISPR-Cas Systems
    • SgRNA
    • Cas9 Nucleases
  • How CRISPR-Cas Works
  • Advantage of the CRISPR-Cas9 System
  • Popularity of CRISPR Genome Editing
  • Major Technological Issues
    • Efficiency
    • Specificity/Off-Target Effect
    • Delivery Systems
    • Immunogenicity Risk for Clinical Applications
  • A New Genome Editing System: CRISPR-Cpf1
  • Studies on Treating Diseases Using Genome Editing
  • Impact of Genome Editing
  • Future of CRISPR

Chapter 4: Applications of Genome Editing

  • Introduction
  • Academic Research
  • Drug Discovery and Development
  • Clinical Therapy
  • Non-transgenic Breeding
  • Diagnostics
  • Other Applications

Chapter 5: Market Segmentation and Forecast

  • Market Overview
  • Major Players
  • Market Segments by Region
  • Market Segments by Application
  • Market Segments by Technology
  • Market Segments by Product Type

Chapter 6: Contract Services Market Analysis

  • Market Overview
  • Major Players
  • Market Share and Projection
  • Comparison with Products Segment

Chapter 7: Research Market Analysis

  • Market Overview
  • Market Share and Projections
  • Patent Analysis
  • Publication Analysis
  • Research Funding Analysis

Chapter 8: Drug Development Market Analysis

  • Market Overview
  • Market Share and Forecast

Chapter 9: Agricultural Biotechnology Market Analysis

  • Market Overview
  • Market Share and Forecast

Chapter 10: Clinical Market Analysis

  • Market Overview
  • Market Share and Forecast
  • Comparison with Non-clinical Market

Chapter 11: Competition Landscape and Opportunities

  • Overview
  • Growth Strategies
    • Licensing and Agreements
    • Collaborations with Big Biopharmaceutical Companies
    • In-house R&D Program
    • Startup
    • Strategic Alliance and Joint Venture
    • Focus on Specific Application Areas
    • Venture Capital Funding
  • Opportunities

Chapter 12: Factors Influencing the Genome Editing Market

  • Introduction
  • Driving Forces
    • New Genome Editing Technologies and Related Advancements
    • New Applications of Genome Editing
    • Need for Precision Medicine
    • Need for Improving Drug Discovery Process
    • Increasing Demand for Synthetic Genes in Synthetic Biology
    • Investments from Both Public and Private Sectors
    • Increased R&D Expenditures in Related Industrial Sectors
    • High Prevalence of Genetic Birth Disorders
    • Concerns on Genetically Modified Crops
  • Factors Limiting the Market's Growth
    • Stringent Regulatory Frameworks and Time-Consuming Approval Processes
    • Research Funding
    • Patent Disputes
    • Governmental Policies and Regulations
    • Regulatory Uncertainty on Genome Edited Crops
    • Ethical Issues

Chapter 13: Company Profiles

  • ADDGENE
  • AGILENT TECHNOLOGIES INC.
  • ALDEVRON
  • ALLELE BIOTECHNOLOGY
  • AMERICAN TYPE CULTURE COLLECTION (ATCC)
  • APPLIED STEMCELL INC.
  • ARBOR BIOTECHNOLOGIE INC.
  • ASTRAZENECA
  • ATUM (DNA2.0)
  • AUSTRALIAN BIORESOURCES LTD.
  • AXOL BIOSCIENCE LTD.
  • BEAM THERAPEUTICS
  • BIOCYTOGEN
  • BIO-RAD LABORATORIES INC.
  • BIOTOOLS CO. LTD.
  • BLUEBIRD BIO
  • B-MOGEN BIOTECHNOLOGIES INC.
  • CALYXT INC.
  • CANOPY BIOSCIENCES
  • CARIBOU BIOSCIENCES INC.
  • CASZYME
  • CELLECTA INC.
  • CELLECTICS S.A.
  • CIBUS
  • CRISPR THERAPEUTICS
  • DESKTOP GENETICS
  • EDITAS MEDICINE
  • GENECOPOEIA
  • GENEWIZ
  • GENSCRIPT
  • HORIZON DISCOVERY
  • INNOVATIVE GENOMICS INITIATIVE
  • INTELLIA THERAPEUTICS INC.
  • INTEGRATED DNA TECHNOLOGIES
  • IXCELLS BIOTECHNOLOGIES
  • JUNO THERAPEUTICS
  • LONZA
  • MAMMOTH BIOSCIENCES
  • MERCK KGAA (SIGMA-ALDRICH)
  • NEW ENGLAND BIOLABS
  • ORIGENE TECHNOLOGIES
  • PRECISION BIOSCIENCES INC.
  • RECOMBINETICS
  • REGENERON PHARMACEUTALS INC.
  • SANGAMO BIOSCIENCES
  • SOLENTIM INC.
  • SYNTHEGO
  • SYSTEM BIOSCIENCES
  • TAKARA BIO USA INC. (CLONTECH)
  • THERMO FISHER SCIENTIFIC
  • TOOLGEN INC.
  • TRANS GENIC INC.
  • TRANSOMIC TECHNOLOGIES INC.
  • TRANSPOSAGEN BIOPHARMACEUTICALS INC.
  • VERTEX PHARMACEUTICALS INC.

List of Tables

  • Summary Table: Global Market for Genome Editing, by Region, Through 2023
    • Table 1: Major Companies That Have Business Related to Genome Editing, July 2018
    • Table 2: Distribution of Companies That Have Genome-Editing-Related Businesses, by Region, July 2018
    • Table 3: Distribution of Companies That Have Genome-Editing-Related Businesses, by U.S. State, July 2018
    • Table 4: Global Market for Genome Editing, by Region, Through 2023
    • Table 5: Global Market for Genome Editing, by Application, Through 2023
    • Table 6: U.S. Market for Genome Editing, by Application, Through 2023
    • Table 7: European Market for Genome Editing, by Application, Through 2023
    • Table 8: Asia-Pacific Market for Genome Editing, by Application, Through 2023
    • Table 9: Rest of World Market for Genome Editing, by Application, Through 2023
    • Table 10: Global Market for Genome Editing, by Technology, Through 2023
    • Table 11: U.S. Market for Genome Editing, by Technology, Through 2023
    • Table 12: European Market for Genome Editing, by Technology, Through 2023
    • Table 13: Asia-Pacific Market for Genome Editing, by Technology, Through 2023
    • Table 14: Rest of World Market for Genome Editing, by Technology, Through 2023
    • Table 15: Global Market for Genome Editing, by Product Type, Through 2023
    • Table 16: U.S. Market for Genome Editing, by Product Type, Through 2023
    • Table 17: European Market for Genome Editing, by Product Type, Through 2023
    • Table 18: Asia-Pacific Market for Genome Editing, by Product Type, Through 2023
    • Table 19: Rest of World Market for Genome Editing, by Product Type, Through 2023
    • Table 20: Major Companies That Provide Genome-Editing-Related Services, July 2018
    • Table 21: Global Market for Genome Editing Services, by Region, Through 2023
    • Table 22: Global Market for Genome Editing, by Product Segment, Through 2023
    • Table 23: U.S. Market for Genome Editing, by Product Segment, Through 2023
    • Table 24: European Market for Genome Editing, by Product Segment, Through 2023
    • Table 25: Asia-Pacific Market for Genome Editing, by Product Segment, Through 2023
    • Table 26: Rest of World Market for Genome Editing, by Product Segment, Through 2023
    • Table 27: Global Academic Research Market for Genome Editing, by Region, Through 2023
    • Table 28: Distribution of Genome Editing Patents and Patent Applications at USPTO, by Country, July 31, 2018
    • Table 29: Distribution of U.S. Genome Editing Patents and Patent Applications at USPTO, by State, July 31, 2018
    • Table 30: Distribution of Genome Editing Patents and Patent Applications at WIPO, by Patent Office, July 31, 2018
    • Table 31: Genome Editing Patents and Patent Applications at USPTO, by Application Year, July 31, 2018
    • Table 32: Genome Editing Patents and Patent Applications at WIPO, by Application Year, July 31, 2018
    • Table 33: Genome Editing Patents and Patent Applications at USPTO, by Technology, July 31, 2018
    • Table 34: NIH Funding for Gene/Genome Editing, by Year
    • Table 35: NIH-Funded Research Grants, by Year
    • Table 36: Global Drug Development Market for Genome Editing, by Region, Through 2023
    • Table 37: Global Plant Breeding Market for Genome Editing, by Region, Through 2023
    • Table 38: Global Market for Genome Editing, by Product Segment, Through 2023
    • Table 39: U.S. Market for Genome Editing, by Product Segment, Through 2023
    • Table 40: European Market for Genome Editing, by Product Segment, Through 2023
    • Table 41: Asia-Pacific Market for Genome Editing, by Product Segment, Through 2023
    • Table 42: Rest of World Market for Genome Editing, by Product Segment, Through 2023

List of Figures

  • Summary Figure: Global Market for Genome Editing, by Region, 2017-2023
    • Figure 1: Distribution Share of Companies That Have Genome-Editing-Related Businesses, by Region, July 2018
    • Figure 2: Global Market for Genome Editing, by Region, 2017-2023
    • Figure 3: Global Genome Editing Market Share, by Region, 2017
    • Figure 4: Global Genome Editing Market Share, by Region, 2023
    • Figure 5: Global Genome Editing Market Share, by Application, 2017
    • Figure 6: Global Genome Editing Market Share, by Application, 2023
    • Figure 7: U.S. Genome Editing Market Share, by Application, 2017
    • Figure 8: U.S. Genome Editing Market Share, by Application, 2023
    • Figure 9: European Genome Editing Market Share, by Application, 2017
    • Figure 10: European Genome Editing Market Share, by Application, 2023
    • Figure 11: Asia-Pacific Genome Editing Market Share, by Application, 2017
    • Figure 12: Asia-Pacific Genome Editing Market Share, by Application, 2023
    • Figure 13: Global Genome Editing Market Share, by Technology, 2017
    • Figure 14: Global Genome Editing Market Share, by Technology, 2023
    • Figure 15: U.S. Genome Editing Market Share, by Technology, 2017
    • Figure 16: U.S. Genome Editing Market Share, by Technology, 2023
    • Figure 17: European Genome Editing Market Share, by Technology, 2017
    • Figure 18: European Genome Editing Market Share, by Technology, 2023
    • Figure 19: Asia-Pacific Genome Editing Market Share, by Technology, 2017
    • Figure 20: Asia-Pacific Genome Editing Market Share, by Technology, 2023
    • Figure 21: Global Genome Editing Market Share, by Product Type, 2017
    • Figure 22: Global Genome Editing Market Share, by Product Type, 2023
    • Figure 23: Global Genome Editing Services Market Share, by Region, 2017
    • Figure 24: Global Genome Editing Services Market Share, by Region, 2023
    • Figure 25: Global Genome Editing Market Share, by Product Segment, 2017
    • Figure 26: Global Genome Editing Market Share, by Product Segment, 2023
    • Figure 27: Global Academic Research Market Share of Genome Editing, by Region, 2017
    • Figure 28: Global Academic Research Market Share of Genome Editing, by Region, 2023
    • Figure 29: Genome Editing Patents and Patent Applications Share, by Technology, July 31, 2018
    • Figure 30: CRISPR Publications, by Year, August 3, 2018
    • Figure 31: ZFNs Publications, by Year
    • Figure 32: TALENs Publications, by Year
    • Figure 33: NIH Funding for Gene/Genome Editing, by Year
    • Figure 34: NIH-Funded Research Grants, by Year
    • Figure 35: Global Drug Development Market Share of Genome Editing, by Region, 2017
    • Figure 36: Global Drug Development Market Share of Genome Editing, by Region, 2023
    • Figure 37: Global Plant Breeding Market Share of Genome Editing, by Region, 2017
    • Figure 38: Global Plant Breeding Market Share of Genome Editing, by Region, 2023
    • Figure 39: Global Clinical Genome Editing Market Share, by Region, 2023
    • Figure 40: Global Genome Editing Market Share, by Product Segment, 2023